VitaNova Life Sciences (VNOV) Net Cash Flow Growth (1y) (2018 - 2026)
VitaNova Life Sciences (VNOV) Net Cash Flow Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Akso Health | 2,315,158.81 Bn | 2,315,158.63 Bn | - | - |
| 2 | Mckesson | 92.76 Bn | 89.18 Bn | 4.04 Bn | -78.03% |
| 3 | Cencora | 52.82 Bn | 50.83 Bn | 3.59 Bn | 136.31% |
| 4 | Cardinal Health | 52.17 Bn | 48.39 Bn | 2.50 Bn | 337.50% |
| 5 | Henry Schein | 9.19 Bn | 9.71 Bn | 1.07 Bn | -248.15% |
| 6 | Accendra Health | 246.88 Mn | -90.00 Mn | 312.39 Mn | 477.50% |
| 7 | Edap Tms | 161.92 Mn | 146.92 Mn | 8.15 Mn | 41.83% |
| 8 | 111 | 107.47 Mn | 25.61 Mn | 23.58 Mn | 176.76% |
| 9 | Cosmos Health | 9.42 Mn | 7.26 Mn | 1.38 Mn | -488.71% |
| 10 | VitaNova Life Sciences | - | - | 316,343.00 | -149.55% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | -149.55% |
| Oct 31, 2025 | 162.03% |
| Jul 31, 2025 | 158.44% |
| Apr 30, 2025 | 275.38% |
| Jan 31, 2025 | -77.44% |
| Jul 31, 2024 | -5,071.87% |
| Apr 30, 2024 | -9,323.19% |
| Jan 31, 2024 | 3,443.49% |
| Jul 31, 2023 | -228.71% |
| Apr 30, 2023 | 83.48% |
| Jan 31, 2023 | -561.22% |
| Oct 31, 2022 | -83.26% |
| Oct 31, 2018 | -83.66% |
| Jul 31, 2018 | -160.88% |